Literature DB >> 8833047

Laboratory markers of disease activity.

C Richardson1, P Emery.   

Abstract

Rheumatoid arthritis is associated with numerous abnormalities measurable in a laboratory. These are most commonly used to monitor disease but can also provide prognostic information; less frequently they are used to support a clinical diagnosis. In general, quantitative markers are used for monitoring early disease. By contrast, qualitative markers can provide prognostic information of particular relevance to early therapy. The markers with the best features for predication of radiological erosions are the MHC conserved epitope and rheumatoid factor. In established disease most of the quantitative measures indicate poor prognosis. Therefore, the choice of the best marker depends not only on the purpose for which it is desired, but also on the stage of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833047

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  2 in total

1.  Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis.

Authors:  Marlon P Quinones; Sunil K Ahuja; Fabio Jimenez; Jason Schaefer; Edgar Garavito; Arun Rao; George Chenaux; Robert L Reddick; William A Kuziel; Seema S Ahuja
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

2.  Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.

Authors:  Tânia Silvia Fröde; Patrícia Tenconi; Marilei Reynaud Debiasi; Yara Santos Medeiros
Journal:  Mediators Inflamm       Date:  2002-12       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.